KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
9.21
+0.71 (8.35%)
At close: Aug 22, 2025, 4:00 PM
8.90
-0.31 (-3.37%)
After-hours: Aug 22, 2025, 6:56 PM EDT
KALA BIO Employees
KALA BIO had 38 employees as of December 31, 2024. The number of employees decreased by 5 or -11.63% compared to the previous year.
Employees
38
Change (1Y)
-5
Growth (1Y)
-11.63%
Revenue / Employee
n/a
Profits / Employee
-$979,658
Market Cap
64.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | 188 | 52 | 38.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KALA News
- 15 days ago - KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 17 days ago - KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 6 weeks ago - KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) - GlobeNewsWire
- 3 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - KALA BIO Announces Chief Executive Officer Transition - GlobeNewsWire
- 8 months ago - KALA BIO Announces $10,750,000 Private Placement - GlobeNewsWire
- 9 months ago - KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire